- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 261/00 - Derivatives of cyanic acid
Patent holdings for IPC class C07C 261/00
Total number of patents in this class: 57
10-year publication summary
5
|
4
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Asahi Kasei Chemicals Corporation | 655 |
5 |
SK Biopharmaceuticals Co., Ltd. | 263 |
4 |
Covestro Deutschland AG | 2774 |
3 |
Arbor Pharmaceuticals, LLC | 69 |
2 |
ISP Investments Inc. | 456 |
2 |
Signature Therapeutics, Inc. | 37 |
2 |
Waters Technologies Corporation | 1714 |
2 |
XenoPort, Inc. | 85 |
2 |
Merck Sharp & Dohme LLC | 3756 |
2 |
Hoffmann-La Roche Inc. | 3484 |
1 |
BASF SE | 21039 |
1 |
Xerox Corporation | 6983 |
1 |
Honeywell International Inc. | 13552 |
1 |
Mitsui Chemicals, Inc. | 3239 |
1 |
Amyris, Inc. | 376 |
1 |
Bio-Pharm Solutions Co., Ltd. | 60 |
1 |
Cellix Bio Private Limited | 52 |
1 |
CTC bio, Inc. | 45 |
1 |
Daiichi Sankyo Company, Limited | 1875 |
1 |
Emulsion Technology Co., Ltd. | 21 |
1 |
Other owners | 22 |